Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schnabl

Showing results (41-50 of 283) with videos related to

Pageof 29
Sort By:
Journal of Hepatology|June 8, 2023
Intestinal clock modulates rhythmic hepatic metabolismMarcos F Fondevila, Bernd Schnabl
Journal of Hepatology|May 1, 2026
Letter in response to Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmesMarcos F Fondevila, Bernd Schnabl
World Journal of Hepatology|May 9, 2012
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver diseaseArthur W Yan, Bernd Schnabl
Clinical and Molecular Hepatology|September 11, 2020
From intestinal dysbiosis to alcohol-associated liver diseaseBeatriz Garcia Mendes, Bernd Schnabl
Gastroenterology|January 21, 2014
Interactions between the intestinal microbiome and liver diseasesBernd Schnabl, David A Brenner
Nature Reviews. Microbiology|June 14, 2023
The gut-liver axis and gut microbiota in health and liver diseaseCynthia L Hsu, Bernd Schnabl
Gut|June 22, 2012
Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitisBernd Schnabl, David A Brenner
Nature Reviews. Gastroenterology & Hepatology|November 16, 2021
Bacteriophages and their potential for treatment of gastrointestinal diseasesYi Duan, Ry Young, Bernd Schnabl
Microbial Cell (Graz, Austria)|August 29, 2024
Fecal gelatinase does not predict mortality in patients with alcohol-associated hepatitisYongqiang Yang, Phillipp Hartmann, Bernd Schnabl
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2020
Targeting pathobionts for the treatment of alcohol-associated liver diseaseSonja Lang, Münevver Demir, Bernd Schnabl
Pageof 29

Showing results (41-50 of 283) with videos related to

Sort By:
Pageof 29
Journal of Hepatology|June 8, 2023
Intestinal clock modulates rhythmic hepatic metabolismMarcos F Fondevila, Bernd Schnabl
Journal of Hepatology|May 1, 2026
Letter in response to Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmesMarcos F Fondevila, Bernd Schnabl
World Journal of Hepatology|May 9, 2012
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver diseaseArthur W Yan, Bernd Schnabl
Clinical and Molecular Hepatology|September 11, 2020
From intestinal dysbiosis to alcohol-associated liver diseaseBeatriz Garcia Mendes, Bernd Schnabl
Gastroenterology|January 21, 2014
Interactions between the intestinal microbiome and liver diseasesBernd Schnabl, David A Brenner
Nature Reviews. Microbiology|June 14, 2023
The gut-liver axis and gut microbiota in health and liver diseaseCynthia L Hsu, Bernd Schnabl
Gut|June 22, 2012
Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitisBernd Schnabl, David A Brenner
Nature Reviews. Gastroenterology & Hepatology|November 16, 2021
Bacteriophages and their potential for treatment of gastrointestinal diseasesYi Duan, Ry Young, Bernd Schnabl
Microbial Cell (Graz, Austria)|August 29, 2024
Fecal gelatinase does not predict mortality in patients with alcohol-associated hepatitisYongqiang Yang, Phillipp Hartmann, Bernd Schnabl
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2020
Targeting pathobionts for the treatment of alcohol-associated liver diseaseSonja Lang, Münevver Demir, Bernd Schnabl
Pageof 29